Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Nephrology
Published in: BMC Nephrology 1/2024

Open Access 01-12-2024 | Chronic Kidney Disease | Research

Primary and specialist care interaction and referral patterns for individuals with chronic kidney disease: a narrative review

Authors: Clyson Mutatiri, Angela Ratsch, Matthew McGrail, Sree Krishna Venuthurupalli, Srinivas Kondalsamy Chennakesavan

Published in: BMC Nephrology | Issue 1/2024

Login to get access

Abstract

Background

Timely referral of individuals with chronic kidney disease from primary care to secondary care is evidenced to improve patient outcomes, especially for those whose disease progresses to kidney failure requiring kidney replacement therapy. A shortage of specialist nephrology services plus no consistent criteria for referral and reporting leads to referral pattern variability in the management of individuals with chronic kidney disease.

Objective

The objective of this review was to explore the referral patterns of individuals with chronic kidney disease from primary care to specialist nephrology services. It focused on the primary-specialist care interface, optimal timing of referral to nephrology services, adequacy of preparation for kidney replacement therapy, and the role of clinical criteria vs. risk-based prediction tools in guiding the referral process.

Methods

A narrative review was utilised to summarise the literature, with the intent of providing a broad-based understanding of the referral patterns for patients with chronic kidney disease in order to guide clinical practice decisions. The review identified original English language qualitative, quantitative, or mixed methods publications as well as systematic reviews and meta-analyses available in PubMed and Google Scholar from their inception to 24 March 2023.

Results

Thirteen papers met the criteria for detailed review. We grouped the findings into three main themes: (1) Outcomes of the timing of referral to nephrology services, (2) Adequacy of preparation for kidney replacement therapy, and (3) Comparison of clinical criteria vs. risk-based prediction tools. The review demonstrated that regardless of the time frame used to define early vs. late referral in relation to the start of kidney replacement therapy, better outcomes are evidenced in patients referred early.

Conclusions

This review informs the patterns and timing of referral for pre-dialysis specialist care to mitigate adverse outcomes for individuals with chronic kidney disease requiring dialysis. Enhancing current risk prediction equations will enable primary care clinicians to accurately predict the risk of clinically important outcomes and provide much-needed guidance on the timing of referral between primary care and specialist nephrology services.
Literature
1.
Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011;80(12):1258–70.PubMedCrossRef
2.
Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260–72.PubMedCrossRef
3.
Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164(6):659–63.PubMedCrossRef
4.
Wen CP, Cheng TYD, Tsai MK, Chang YC, Chan HT, Tsai SP, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet. 2008;371(9631):2173–82.PubMedCrossRef
5.
Levey A, Atkins R, Coresh J, Cohen E, Collins A, Eckardt K-U, et al. Chronic kidney disease as a global public health problem: approaches and initiatives–a position statement from kidney disease improving global outcomes. Kidney Int. 2007;72(3):247–59.PubMedCrossRef
6.
Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073–81.CrossRef
7.
Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, Abebe M, et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the global burden of Disease Study 2017. Lancet. 2020;395(10225):709–33.CrossRef
8.
Australian Institute of Health Welfare. Chronic kidney disease prevalence among Australian adults over time. Canberra: AIHW; 2018.
9.
Australian Institute of Health Welfare. Chronic kidney disease: Australian facts. Canberra: AIHW; 2023.
10.
Hayashi T, Kimura T, Yasuda K, Sasaki K, Obi Y, Nagayama H, et al. Early nephrology referral 6 months before dialysis initiation can reduce early death but does not improve long-term cardiovascular outcome on dialysis. Circ J. 2016;80(4):1008–16.PubMedCrossRef
11.
Sabath E, Vega O, Correa-Rotter R. Early referral to the nephrologist: impact on initial hospitalization and the first 6 months of continuous ambulatory peritoneal dialysis. Rev Invest Clin. 2003;55(5):489–93.PubMed
12.
Huisman RM. The deadly risk of late referral. Nephrol Dial Transpl. 2004;19(9):2175–80.CrossRef
13.
Smart NA, Titus TT. Outcomes of early versus late nephrology referral in chronic kidney disease: a systematic review. Am J Med. 2011;124(11):1073–e802.PubMedCrossRef
14.
Sharif MU, Elsayed ME, Stack AG. The global nephrology workforce: emerging threats and potential solutions! Clin Kidney J. 2016;9(1):11–22.PubMedCrossRef
15.
Bello AK, Levin A, Manns BJ, Feehally J, Drueke T, Faruque L, et al. Effective CKD care in European countries: challenges and opportunities for health policy. Am J Kidney Dis. 2015;65(1):15–25.PubMedCrossRef
16.
Parker MG, Ibrahim T, Shaffer R, Rosner MH, Molitoris BA. The future nephrology workforce: will there be one? Clin J Am Soc Nephrol. 2011;6(6):1501–6.PubMedCrossRef
17.
Mehrotra R, Shaffer RN, Molitoris BA, editors. Implications of a nephrology workforce shortage for dialysis patient care. Semin Dial; 2011.
18.
Katz IJ, Gerntholtz T, Naicker S. Africa and nephrology: the forgotten continent. Nephron Clin Pract. 2011;117(4):320–7.CrossRef
19.
Osman MA, Alrukhaimi M, Ashuntantang GE, Bellorin-Font E, Gharbi MB, Braam B, et al. Global nephrology workforce: gaps and opportunities toward a sustainable kidney care system. Kidney Int Suppl. 2018;8(2):52–63.CrossRef
20.
Sozio SM, Pivert KA, Caskey FJ, Levin A. The state of the global nephrology workforce: a joint ASN–ERA-EDTA–ISN investigation. Kidney Int. 2021;100(5):995–1000.PubMedCrossRef
21.
22.
Amos L, Toussaint N, Phoon R, Elias T, Levidiotis V, Campbell S, et al. Increase in nephrology advanced trainee numbers in Australia and associated reduction in clinical exposure over the past decade. Intern Med J. 2013;43(3):287–93.PubMedCrossRef
23.
Levin A, Stevens PE, Bilous RW, Coresh J, De Francisco AL, De Jong PE, et al. Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):1–150.
24.
Martinez YV, Benett I, Lewington AJ, Wierzbicki AS. Chronic kidney disease: summary of updated NICE guidance. BMJ. 2021;374.
25.
26.
Robinson BM, Akizawa T, Jager KJ, Kerr PG, Saran R, Pisoni RL. Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices. Lancet. 2016;388(10041):294–306.PubMedPubMedCentralCrossRef
27.
Saran R, Robinson B, Abbott KC, Agodoa LY, Bhave N, Bragg-Gresham J, et al. US renal data system 2017 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2018;71(3):A7.PubMedPubMedCentralCrossRef
28.
Lonnemann G, Duttlinger J, Hohmann D, Hickstein L, Reichel H. Timely referral to outpatient nephrology care slows progression and reduces treatment costs of chronic kidney diseases. Kidney Int Rep. 2017;2(2):142–51.PubMedCrossRef
29.
Chen JH, Chiu YW, Hwang SJ, Tsai JC, Shi HY, Lin MY. Effect of nephrology referrals and multidisciplinary care programs on renal replacement and medical costs on patients with advanced chronic kidney disease: a retrospective cohort study. Medicine. 2019;98(33):e16808.PubMedPubMedCentralCrossRef
30.
Dharod A, Bundy R, Russell GB, Rice WY 3rd, Golightly CE, Rosenthal GE, et al. Primary care referrals to nephrology in patients with advanced kidney disease. Am J Manag Care. 2020;26(11):468–74.PubMedPubMedCentralCrossRef
31.
Campbell GA, Bolton WK. Referral and comanagement of the patient with CKD. Adv Chronic Kidney Dis. 2011;18(6):420–7.PubMedCrossRef
32.
Haley WE, Beckrich AL, Sayre J, McNeil R, Fumo P, Rao VM, et al. Improving care coordination between nephrology and primary care: a quality improvement initiative using the renal physicians association toolkit. Am J Kidney Dis. 2015;65(1):67–79.PubMedCrossRef
33.
Samal L, Wright A, Waikar SS, Linder JA. Nephrology co-management versus primary care solo management for early chronic kidney disease: a retrospective cross-sectional analysis. BMC Nephrol. 2015;16(1):1–8.CrossRef
34.
Baer G, Lameire N, Van Biesen W. Late referral of patients with end-stage renal disease: an in-depth review and suggestions for further actions. NDT plus. 2010;3(1):17–27.PubMed
35.
Kessler M, Frimat L, Panescu V, Briançon S. Impact of nephrology referral on early and midterm outcomes in ESRD: EPidémiologie De l’Insuffisance REnale Chronique terminale en Lorraine (EPIREL): results of a 2-year, prospective, community-based study. Am J Kidney Dis. 2003;42(3):474–85.PubMedCrossRef
36.
Chan MR, Dall AT, Fletcher KE, Lu N, Trivedi H. Outcomes in patients with chronic kidney disease referred late to nephrologists: a meta-analysis. Am J Med. 2007;120(12):1063–70.PubMedCrossRef
37.
Diegoli H, Silva MC, Machado DS, Cruz CE. Late nephrologist referral and mortality assotiation in dialytic patients. J Bras Nefrol. 2015;37(1):32–7.PubMedCrossRef
38.
Anees M, Hussain Y, Ibrahim M, Ilahi I, Ahmad S, Asif KI, et al. Outcome of chronic kidney disease patients on the basis of referral to nephrologist: a one-year follow-up study. J Coll Physicians Surg Pak. 2018;28(4):304–7.PubMedCrossRef
39.
Wavamunno MD, Harris DC. The need for early nephrology referral. Kidney Int Suppl. 2005;94:S128–32.CrossRef
40.
Winkelmayer WC, Owen WF, Levin R, Avorn J. A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol. 2003;14(2):486–92.PubMedCrossRef
41.
Hughes SA, Mendelssohn JG, Tobe SW, McFarlane PA, Mendelssohn DC. Factors associated with suboptimal initiation of dialysis despite early nephrologist referral. Nephrol Dial Transpl. 2013;28(2):392–7.CrossRef
42.
Levin A, Stevens PE. Early detection of CKD: the benefits, limitations and effects on prognosis. Nat Rev Nephrol. 2011;7(8):446–57.PubMedCrossRef
43.
Greenhalgh T, Thorne S, Malterud K. Time to challenge the spurious hierarchy of systematic over narrative reviews? Eur J Clin Invest. 2018;48(6).
44.
Ferrari R. Writing narrative style literature reviews. Med Writ. 2015;24(4):230–5.CrossRef
45.
Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, et al. Guidance on the conduct of narrative synthesis in systematic reviews. Prod ESRC Methods Programme Version. 2006;1(1):b92.
46.
Fletcher KE, Underwood W, Davis SQ, Mangrulkar RS, McMahon LF, Saint S. Effects of work hour reduction on residents’ lives: a systematic review. JAMA. 2005;294(9):1088–100.PubMedCrossRef
47.
Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20(3):21–35.PubMedCrossRef
48.
Stroupe KT, Fischer MJ, Kaufman JS, O’Hare AM, Sohn MW, Browning MM, et al. Predialysis nephrology care and costs in elderly patients initiating dialysis. Med Care. 2011;49(3):248–56.PubMedCrossRef
49.
Kim DH, Kim M, Kim H, Kim Y-L, Kang S-W, Yang CW, et al. Early referral to a nephrologist improved patient survival: prospective cohort study for end-stage renal disease in Korea. PLoS ONE. 2013;8(1):e55323–e.PubMedPubMedCentralCrossRef
50.
Smart NA, Dieberg G, Ladhani M, Titus T. Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease. Cochrane Database Syst Rev. 2014(6):CD007333.
51.
Gillespie BW, Morgenstern H, Hedgeman E, Tilea A, Scholz N, Shearon T, et al. Nephrology care prior to end-stage renal disease and outcomes among new ESRD patients in the USA. Clin Kidney J. 2015;8(6):772–80.PubMedPubMedCentralCrossRef
52.
Avorn J, Winkelmayer WC, Bohn RL, Levin R, Glynn RJ, Levy E, et al. Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure. J Clin Epidemiol. 2002;55(7):711–6.PubMedCrossRef
53.
Thilly N, Boini S, Loos-Ayav C, Kessler M, Briançon S, Frimat L. Impact of predialysis therapeutic practices on patient outcomes during the first year of dialysis: the Pharmacoepidemiologic AVENIR study. Med Care. 2012:35–42.
54.
Hasegawa T, Bragg-Gresham JL, Yamazaki S, Fukuhara S, Akizawa T, Kleophas W, et al. Greater first-year survival on hemodialysis in facilities in which patients are provided earlier and more frequent pre-nephrology visits. Clin J Am Soc Nephrol. 2009;4(3):595–602.PubMedPubMedCentralCrossRef
55.
Khan SS, Xue JL, Kazmi WH, Gilbertson DT, Obrador GT, Pereira BJ, et al. Does predialysis nephrology care influence patient survival after initiation of dialysis? Kidney Int. 2005;67(3):1038–46.PubMedCrossRef
56.
Singhal R, Hux JE, Alibhai SM, Oliver MJ. Inadequate predialysis care and mortality after initiation of renal replacement therapy. Kidney Int. 2014;86(2):399–406.PubMedCrossRef
57.
Foley RN, Chen S-C, Solid CA, Gilbertson DT, Collins AJ. Early mortality in patients starting dialysis appears to go unregistered. Kidney Int. 2014;86(2):392–8.PubMedCrossRef
58.
Fischer MJ, Stroupe KT, Kaufman JS, O’Hare AM, Browning MM, Sohn MW, et al. Predialysis nephrology care and dialysis-related health outcomes among older adults initiating dialysis. BMC Nephrol. 2016;17(1):103.PubMedPubMedCentralCrossRef
59.
Major RW, Shepherd D, Medcalf JF, Xu G, Gray LJ, Brunskill NJ. The kidney failure risk equation for prediction of end stage renal disease in UK primary care: an external validation and clinical impact projection cohort study. PLoS Med. 2019;16(11):e1002955.PubMedPubMedCentralCrossRef
60.
Duggal V, Montez-Rath ME, Thomas IC, Goldstein MK, Tamura MK. Nephrology referral based on laboratory values, kidney failure risk, or both: a study using veterans affairs health system data. Am J Kidney Dis. 2021.
61.
Bhachu HK, Cockwell P, Subramanian A, Adderley NJ, Gokhale K, Fenton A, et al. Impact of using risk-based stratification on referral of patients with chronic kidney disease from primary care to specialist care in the United Kingdom. Kidney Int Rep. 2021;6(8):2189–99.PubMedPubMedCentralCrossRef
62.
63.
Stack AG. Impact of timing of nephrology referral and pre-ESRD care on mortality risk among new ESRD patients in the United States. Am J Kidney Dis. 2003;41(2):310–8.PubMedCrossRef
64.
Roderick P, Jones C, Drey N, Blakeley S, Webster P, Goddard J, et al. Late referral for end-stage renal disease: a region-wide survey in the south west of England. Nephrol Dial Transpl. 2002;17(7):1252–9.CrossRef
65.
Ravani P, Quinn R, Fiocco M, Liu P, Al-Wahsh H, Lam N, et al. Association of age with risk of kidney failure in adults with stage IV chronic kidney disease in Canada. JAMA Netw Open. 2020;3(9):e2017150–e.PubMedPubMedCentralCrossRef
66.
Jose MD, Raj R, Jose K, Kitsos A, Saunder T, McKercher C, et al. Competing risks of death and kidney failure in a cohort of Australian adults with severe chronic kidney disease. Med J Aust. 2022;216(3):140–6.PubMedCrossRef
67.
Djukanović L, Lezaic V, Dimković N, Peruničić Peković G, Bukvić D, Bajčetić S, et al. Early detection of chronic kidney disease: collaboration of Belgrade nephrologists and primary care physicians. Nefrologia (Engl Ed). 2012;32(1):59–66.
68.
Mathew T, Corso O. Early detection of chronic kidney disease in Australia: which way to go? Nephrology. 2009;14(4):367–73.PubMedCrossRef
69.
Gansevoort RT, Bakker SJ, De Jong PE. Early detection of progressive chronic kidney disease: is it feasible? J Am Soc Nephrol. 2006;17(5):1218–20.PubMedCrossRef
70.
Black C, Sharma P, Scotland G, McCullough K, McGurn D, Robertson L, et al. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis. Health Technol Assess. 2010;14(21):1–184.PubMedCrossRef
71.
Winkelmayer WC, Liu J, Chertow GM, Tamura MK. Predialysis nephrology care of older patients approaching end-stage renal disease. Arch Intern Med. 2011;171(15):1371–8.PubMedPubMedCentralCrossRef
72.
Lee J, Lee JP, Park JI, Hwang JH, Jang HM, Choi JY, et al. Early nephrology referral reduces the economic costs among patients who start renal replacement therapy: a prospective cohort study in Korea. PLoS ONE. 2014;9(6):e99460.PubMedPubMedCentralCrossRef
73.
Kazmi WH, Obrador GT, Khan SS, Pereira BJ, Kausz AT. Late nephrology referral and mortality among patients with end-stage renal disease: a propensity score analysis. Nephrol Dial Transpl. 2004;19(7):1808–14.CrossRef
74.
Selim G, Stojceva-Taneva O, Spasovski G, Tozija L, Grozdanovski R, Georgievska-Ismail L, et al. Timing of nephrology referral and initiation of dialysis as predictors for survival in hemodialysis patients: 5-year follow-up analysis. Int Urol Nephrol. 2015;47(1):153–60.PubMedCrossRef
75.
Kim DH, Kim M, Kim H, Kim YL, Kang SW, Yang CW, et al. Early referral to a nephrologist improved patient survival: prospective cohort study for end-stage renal disease in Korea. PLoS ONE. 2013;8(1):e55323.PubMedPubMedCentralCrossRef
76.
Nakamura S, Nakata H, Yoshihara F, Kamide K, Horio T, Nakahama H, et al. Effect of early nephrology referral on the initiation of hemodialysis and survival in patients with chronic kidney disease and cardiovascular diseases. Circ J. 2007;71(4):511–6.PubMedCrossRef
77.
Obrador GT, Pereira B. Early referral to the nephrologist and timely initiation of renal replacement therapy: a paradigm shift in the management of patients with chronic renal failure. Am J Kidney Dis. 1998;31(3):398–417.PubMedCrossRef
78.
Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G, et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease: a meta-analysis of patient-level data. Ann Intern Med. 2001;135(2):73–87.PubMedCrossRef
79.
Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345(12):851–60.PubMedCrossRef
80.
Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–89.PubMedCrossRef
81.
Ravani P, Marinangeli G, Tancredi M, Malverti F. Multidisciplinary chronic kidney disease management improves survival on dialysis. J Nephrol. 2003;16(6):870–7.PubMed
82.
Levin A, Lewis M, Mortiboy P, Faber S, Hare I, Porter EC, et al. Multidisciplinary predialysis programs: quantification and limitations of their impact on patient outcomes in two Canadian settings. Am J Kidney Dis. 1997;29(4):533–40.PubMedCrossRef
83.
Buck J, Baker R, Cannaby A-M, Nicholson S, Peters J, Warwick G. Why do patients known to renal services still undergo urgent dialysis initiation? A cross-sectional survey. Nephrol Dial Transpl. 2007;22(11):3240–5.CrossRef
84.
Crews DC, Jaar BG, Plantinga LC, Kassem HS, Fink NE, Powe NR. Inpatient hemodialysis initiation: reasons, risk factors and outcomes. Nephron Clin Pract. 2010;114(1):c19–28.PubMedCrossRef
85.
Marrón B, Ortiz A, de Sequera P, Martín-Reyes G, de Arriba G, Lamas JM, et al. Impact of end-stage renal disease care in planned dialysis start and type of renal replacement therapy—a Spanish multicentre experience. Nephrol Dial Transpl. 2006;21(suppl2):ii51–5.CrossRef
86.
Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG. Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol. 2004;15(2):477–86.PubMedCrossRef
87.
Quinn RR, Oliver MJ, Devoe D, Poinen K, Kabani R, Kamar F, et al. The effect of predialysis fistula attempt on risk of all-cause and access-related death. J Am Soc Nephrol. 2017;28(2):613–20.PubMedCrossRef
88.
Tang TT, Levin ML, Ahya SN, Boobes K, Hasan MH. Initiation of maintenance hemodialysis through central venous catheters: study of patients’ perceptions based on a structured questionnaire. BMC Nephrol. 2019;20(1):1–6.CrossRef
89.
Ravani P, Palmer SC, Oliver MJ, Quinn RR, MacRae JM, Tai DJ, et al. Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol. 2013;24(3):465–73.PubMedPubMedCentralCrossRef
90.
Xue JL, Peter WLS, Ebben JP, Everson SE, Collins AJ. Anemia treatment in the pre-ESRD period and associated mortality in elderly patients. Am J Kidney Dis. 2002;40(6):1153–61.PubMedCrossRef
91.
Rognant N, Laville M. Early mortality in dialysis and adequacy of predialysis renal care: the picture is more complex than we thought. Kidney Int. 2014;86(2):238–40.PubMedCrossRef
92.
Chu CD, Lamprea-Montealegre JA, Estrella MM. Too many for too few: finding appropriate nephrology referrals for patients with CKD that optimize outcomes. Am J Kidney Dis. 2022;79(3):330–2.PubMedCrossRef
93.
94.
Matsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH, Jee SH, et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA. 2012;307(18):1941–51.PubMedCrossRef
95.
Shlipak MG, Matsushita K, Ärnlöv J, Inker LA, Katz R, Polkinghorne KR, et al. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med. 2013;369(10):932–43.PubMedPubMedCentralCrossRef
96.
Oliva-Damaso N, Delanaye P, Oliva-Damaso E, Payan J, Glassock RJ. Risk-based versus GFR threshold criteria for nephrology referral in chronic kidney disease. Clin Kidney J. 2022;15(11):1996–2005.PubMedPubMedCentralCrossRef
97.
NICE Guideline. Evidence review for the best combination of measures to identify increased risk of progression in adults, children and young people. London: National Institute for Health and Care Excellence; 2021. p. 203. Report No.
98.
Hingwala J, Wojciechowski P, Hiebert B, Bueti J, Rigatto C, Komenda P, et al. Risk-based triage for nephrology referrals using the kidney failure risk equation. Can J Kidney Health Dis. 2017;4:2054358117722782.PubMedPubMedCentralCrossRef
Metadata
Title
Primary and specialist care interaction and referral patterns for individuals with chronic kidney disease: a narrative review
Authors
Clyson Mutatiri
Angela Ratsch
Matthew McGrail
Sree Krishna Venuthurupalli
Srinivas Kondalsamy Chennakesavan
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2024
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-024-03585-z

Other articles of this Issue 1/2024

BMC Nephrology 1/2024 Go to the issue

Research

Predictive performance of two types of urinary biomarkers for renal non-recovery in sepsis-associated acute kidney injury: a prospective observational study

Research

Benefit finding in chronic kidney disease patients receiving hemodialysis: a cross-sectional study

Case Report

Polycystic intrahepatic infection caused by Enterococcus casseliflavus: a case report and literature review

Research

Educational level and gender are associated with emotional well-being in a cohort of Dutch dialysis patients

Study Protocol

The Intersectoral Coordination Unit for the Sustainable Intensification of Peritoneal Dialysis in Schleswig–Holstein (SKIP-SH) cohort study

Research

Oxidative stress in patients with coronavirus disease and end-stage renal disease: a pilot study
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits